vs

Side-by-side financial comparison of Everus Construction Group, Inc. (ECG) and StoneX Group Inc. (SNEX). Click either name above to swap in a different company.

StoneX Group Inc. is the larger business by last-quarter revenue ($1.2B vs $1.0B, roughly 1.2× Everus Construction Group, Inc.). StoneX Group Inc. runs the higher net margin — 11.6% vs 5.5%, a 6.1% gap on every dollar of revenue. On growth, StoneX Group Inc. posted the faster year-over-year revenue change (81.0% vs 33.2%). Everus Construction Group, Inc. produced more free cash flow last quarter ($23.5M vs $-1.3B). Over the past eight quarters, StoneX Group Inc.'s revenue compounded faster (53.5% CAGR vs 27.1%).

StoneX Group Inc. is an American financial services company. The company operates in six areas: commercial hedging, global payments, securities, physical commodities, foreign exchange and clearing and execution services (CES).

ECG vs SNEX — Head-to-Head

Bigger by revenue
SNEX
SNEX
1.2× larger
SNEX
$1.2B
$1.0B
ECG
Growing faster (revenue YoY)
SNEX
SNEX
+47.9% gap
SNEX
81.0%
33.2%
ECG
Higher net margin
SNEX
SNEX
6.1% more per $
SNEX
11.6%
5.5%
ECG
More free cash flow
ECG
ECG
$1.3B more FCF
ECG
$23.5M
$-1.3B
SNEX
Faster 2-yr revenue CAGR
SNEX
SNEX
Annualised
SNEX
53.5%
27.1%
ECG

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ECG
ECG
SNEX
SNEX
Revenue
$1.0B
$1.2B
Net Profit
$55.3M
$139.0M
Gross Margin
11.6%
Operating Margin
6.8%
15.4%
Net Margin
5.5%
11.6%
Revenue YoY
33.2%
81.0%
Net Profit YoY
60.4%
63.3%
EPS (diluted)
$1.09
$2.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ECG
ECG
SNEX
SNEX
Q4 25
$1.0B
$1.2B
Q3 25
$986.8M
$32.7B
Q2 25
$921.5M
$851.2M
Q1 25
$826.6M
$820.4M
Q4 24
$759.6M
$663.1M
Q3 24
$761.0M
$31.1B
Q2 24
$703.4M
$571.8M
Q1 24
$625.7M
$509.2M
Net Profit
ECG
ECG
SNEX
SNEX
Q4 25
$55.3M
$139.0M
Q3 25
$57.0M
$85.7M
Q2 25
$52.8M
$63.4M
Q1 25
$36.7M
$71.7M
Q4 24
$34.5M
$85.1M
Q3 24
$41.8M
$76.7M
Q2 24
$39.0M
$61.9M
Q1 24
$28.2M
$53.1M
Gross Margin
ECG
ECG
SNEX
SNEX
Q4 25
11.6%
Q3 25
12.6%
3.7%
Q2 25
13.0%
Q1 25
11.2%
Q4 24
11.4%
Q3 24
11.8%
3.0%
Q2 24
12.6%
Q1 24
11.9%
Operating Margin
ECG
ECG
SNEX
SNEX
Q4 25
6.8%
15.4%
Q3 25
7.3%
0.3%
Q2 25
7.9%
-1.3%
Q1 25
6.2%
-1.0%
Q4 24
6.1%
-3.2%
Q3 24
7.1%
-0.0%
Q2 24
7.3%
-4.7%
Q1 24
6.2%
-2.5%
Net Margin
ECG
ECG
SNEX
SNEX
Q4 25
5.5%
11.6%
Q3 25
5.8%
0.3%
Q2 25
5.7%
7.4%
Q1 25
4.4%
8.7%
Q4 24
4.5%
12.8%
Q3 24
5.5%
0.2%
Q2 24
5.5%
10.8%
Q1 24
4.5%
10.4%
EPS (diluted)
ECG
ECG
SNEX
SNEX
Q4 25
$1.09
$2.50
Q3 25
$1.11
$0.72
Q2 25
$1.03
$1.22
Q1 25
$0.72
$1.41
Q4 24
$0.68
$1.69
Q3 24
$0.82
$2.32
Q2 24
$0.76
$1.25
Q1 24
$0.55
$1.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ECG
ECG
SNEX
SNEX
Cash + ST InvestmentsLiquidity on hand
$1.6B
Total DebtLower is stronger
$281.5M
Stockholders' EquityBook value
$629.8M
$2.5B
Total Assets
$1.7B
$47.8B
Debt / EquityLower = less leverage
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ECG
ECG
SNEX
SNEX
Q4 25
$1.6B
Q3 25
$1.6B
Q2 25
$1.3B
Q1 25
$1.3B
Q4 24
$1.4B
Q3 24
$553.0K
$1.3B
Q2 24
$1.2B
Q1 24
$1.3B
Total Debt
ECG
ECG
SNEX
SNEX
Q4 25
$281.5M
Q3 25
$285.1M
Q2 25
$288.6M
Q1 25
$292.1M
Q4 24
$295.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ECG
ECG
SNEX
SNEX
Q4 25
$629.8M
$2.5B
Q3 25
$573.0M
$2.4B
Q2 25
$514.4M
$2.0B
Q1 25
$460.2M
$1.9B
Q4 24
$422.6M
$1.8B
Q3 24
$453.3M
$1.7B
Q2 24
$490.0M
$1.6B
Q1 24
$464.3M
$1.5B
Total Assets
ECG
ECG
SNEX
SNEX
Q4 25
$1.7B
$47.8B
Q3 25
$1.6B
$45.3B
Q2 25
$1.5B
$34.3B
Q1 25
$1.4B
$31.3B
Q4 24
$1.3B
$29.6B
Q3 24
$1.3B
$27.5B
Q2 24
$25.9B
Q1 24
$25.7B
Debt / Equity
ECG
ECG
SNEX
SNEX
Q4 25
0.45×
Q3 25
0.50×
Q2 25
0.56×
Q1 25
0.63×
Q4 24
0.70×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ECG
ECG
SNEX
SNEX
Operating Cash FlowLast quarter
$48.2M
$-1.3B
Free Cash FlowOCF − Capex
$23.5M
$-1.3B
FCF MarginFCF / Revenue
2.3%
-106.4%
Capex IntensityCapex / Revenue
2.4%
1.3%
Cash ConversionOCF / Net Profit
0.87×
-9.08×
TTM Free Cash FlowTrailing 4 quarters
$90.0M
$3.5B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ECG
ECG
SNEX
SNEX
Q4 25
$48.2M
$-1.3B
Q3 25
$76.2M
$3.5B
Q2 25
$25.3M
$1.5B
Q1 25
$7.1M
$-154.5M
Q4 24
$-477.8M
Q3 24
$78.9M
$192.6M
Q2 24
$-622.1M
Q1 24
$21.9M
$784.0M
Free Cash Flow
ECG
ECG
SNEX
SNEX
Q4 25
$23.5M
$-1.3B
Q3 25
$65.7M
$3.5B
Q2 25
$12.3M
$1.5B
Q1 25
$-11.4M
$-169.8M
Q4 24
$-491.4M
Q3 24
$60.9M
$175.9M
Q2 24
$-640.5M
Q1 24
$12.6M
$766.6M
FCF Margin
ECG
ECG
SNEX
SNEX
Q4 25
2.3%
-106.4%
Q3 25
6.7%
10.7%
Q2 25
1.3%
173.3%
Q1 25
-1.4%
-20.7%
Q4 24
-74.1%
Q3 24
8.0%
0.6%
Q2 24
-112.0%
Q1 24
2.0%
150.5%
Capex Intensity
ECG
ECG
SNEX
SNEX
Q4 25
2.4%
1.3%
Q3 25
1.1%
0.1%
Q2 25
1.4%
1.9%
Q1 25
2.2%
1.9%
Q4 24
2.1%
Q3 24
2.4%
0.1%
Q2 24
3.2%
Q1 24
1.5%
3.4%
Cash Conversion
ECG
ECG
SNEX
SNEX
Q4 25
0.87×
-9.08×
Q3 25
1.34×
41.18×
Q2 25
0.48×
23.52×
Q1 25
0.19×
-2.15×
Q4 24
-5.61×
Q3 24
1.89×
2.51×
Q2 24
-10.05×
Q1 24
0.77×
14.76×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

SNEX
SNEX

Segment breakdown not available.

Related Comparisons